Á¶ÁøÇö ¸íÀÇ

º¹ºÎ´ëµ¿¸Æ·ù, ¸»ÃÊÇ÷°ü µî Ç÷°ü°Ç°­ Ã¥ÀÓÁö´Â Ç÷°ü¿Ü°ú ±ÇÀ§ÀÚ

Á¶ÁøÇö ¸íÀÇ

  • ¼Ò ¼Ó
    °­µ¿°æÈñ´ëÇб³º´¿ø Ç÷°ü¿Ü°ú
  • Àü¹®ºÐ¾ß
    ÇÏÁöÁ¤¸Æ·ù, µ¿¸Æ·ù¼ö¼ú, °æµ¿¸Æ³»¸·ÀýÁ¦¼ú, ´ç´¢¹ß ¸»ÃÊÇ÷°ü ÀÎÅͺ¥¼Ç. µ¿Á¤¸Æ·ç ¼ö¼ú/ÀÎÅͺ¥¼Ç

Á¶¼±´ë ÀǴ븦 Á¹¾÷Çϰí ÇѾç´ë ÀÇ´ë¿Í ¼º±Õ°ü´ë ÀÇ´ë¿¡¼­ ¼®¡¤¹Ú»ç ÇÐÀ§¸¦ ÃëµæÇß´Ù. ÇöÀç °­µ¿°æÈñ´ëº´¿ø ¿Ü°ú ±³¼ö·Î ÀçÁ÷ ÁßÀ̸ç, ¿Ü°ú °úÀå, ±³À°¼ö·ÃºÎÀå µîÀ» ¿ªÀÓÇß´Ù. ¶ÇÇÑ ´ëÇÑÇ÷°ü¿Ü°úÇÐȸ Àü»êÁ¤º¸À§¿øÀå, ´ëÇѿܰúÃÊÀ½ÆÄÇÐȸ Áø·á±Ç°í¾ÈÀ§¿øÀå, ´ëÇÑÁ¤¸ÆÇÐȸ ÀÌ»ç µî ÁÖ¿ä ÇÐȸ ÀÓ¿øÀ¸·Îµµ Ȱ¹ßÇÏ°Ô È°µ¿ ÁßÀÌ´Ù.ÁÖ¿ä Áø·á¡¤¿¬±¸ ºÐ¾ß´Â ÇÏÁöÁ¤¸Æ·ù, µ¿¸Æ·ù¼ö¼ú, °æµ¿¸Æ³»¸·ÀýÁ¦¼ú, ´ç´¢¹ß, ¸»ÃÊÇ÷°ü ÀÎÅͺ¥¼Ç µîÀÌ´Ù. °ü·Ã ³í¹® ¶ÇÇÑ ¼öÂ÷·Ê Á¦ÀÛ¡¤¹ßÇ¥ÇßÀ¸¸ç, ¡®ÇÏÁöÁ¤¸ÆÃÊÀ½ÆÄ¡¯, ¡®Ç÷°üÃÊÀ½ÆÄ¡¯ µî°ú °°Àº ÀÇÇÐ ¼­Àûµµ Æì³Â´Ù. 2013³â¿¡´Â ÃÖÃÊ·Î Çѱ¹ÀÎ º¹ºÎ´ëµ¿¸Æ·ù À¯º´·ü¿¡ ´ëÇÑ ¿¬±¸°á°ú¸¦ ¹ßÇ¥Çϱ⵵ Çß´Ù.

¸íÀÇÇÁ·ÎÇÊ ¸íÀÇ ÇÁ·ÎÇÊ

ÇзÂ

Educational Background
  • Á¶¼±´ë ÀÇ´ë Çлç
  • ÇѾç´ë ÀÇ´ë ¼®»ç
  • ¼º±Õ°ü´ë ÀÇ´ë ¹Ú»ç

ÁÖ¿ä°æ·Â

Work Experience
  • úÞ) °æÈñ´ëÇб³ ¿Ü°úÇб³½Ç ±³¼ö
  • úÞ) ÇöÀç °­µ¿°æÈñ´ëÇб³º´¿ø ¿Ü°ú ±³¼ö
  • °­µ¿°æÈñ´ëÇб³º´¿ø ¿Ü°ú °úÀå (2019 ~ 2022)
  • °­µ¿°æÈñ´ëÇб³º´¿ø ±³À°¼ö·ÃºÎÀå (2019 ~ 2023)
  • ¹Ì±¹ Stanford Hospital & Clinics Ç÷°ü ¹× °æÇ÷°ü¿Ü°ú ¿¬¼ö (2008 ~ 2009)
  • ¹Ì±¹ RVT, RPVI, RDMS, RDCS Ãëµæ (2005 ~ 2006)
  • ÇÑÀüÀÇ·áÀç´Ü ÇÑÀϺ´¿ø ¿Ü°ú °úÀå (2005 ~ 2008)
  • ¼º±Õ°ü´ëÇб³ »ï¼º¼­¿ïº´¿ø Ç÷°ü¿Ü°ú ÀÓ»ó°­»ç (2003 ~ 2005)
  • Á¦1±º¼öÁö¿ø»ç·ÉºÎ Àǹ«½ÇÀå (2000 ~ 2003)
  • ¼º±Õ°ü´ëÇб³ »ï¼º¼­¿ïº´¿ø ¿Ü°ú ·¹Áö´øÆ® (1996 ~ 2000)

¼ö»ó³»¿ª

Awards List
  • ¾Æ½Ã¾ÆÇ÷°ü¿Ü°úÇÐȸ ¿ì¼ö±¸¿¬»ó (2020)
  • ´ëÇÑÇ÷°ü¿Ü°úÇÐȸ ¿ì¼ö³í¹®»ó (2017)
  • ´ëÇÑÁ¤¸ÆÇÐȸ ¿ì¼ö±¸¿¬»ó (2017)
  • ´ëÇѿܰúÃÊÀ½ÆÄÇÐȸ ¿ì¼ö±¸¿¬»ó (2017)
  • ÇÑÀÏÁ¶ÀÎÆ®¹ÌÆÃ ¿ì¼ö±¸¿¬»ó (2015)
  • ÇÑÀÏÁ¶ÀÎÆ®¹ÌÆÃ ¿ì¼ö±¸¿¬»ó (2013)
  • ¾Æ½Ã¾ÆÇ÷°ü¿Ü°úÇÐȸ ¿ì¼ö±¸¿¬»ó (2010)
  • ÇÑÀÏÁ¶ÀÎÆ®¹ÌÆÃ ÀþÀº¿¬±¸ÀÚ»ó (2005)

ÇÐȸȰµ¿

Academic activities
  • 2018 ~ ÇöÀç´ëÇÑÇ÷°ü¿Ü°úÇÐȸ Àü»êÁ¤º¸À§¿øÀå
  • 2018 ~ ÇöÀçDirector of the Interactive Vascular Diagnosis and Treatment (IVDT)
  • 2016 ~ ÇöÀç´ëÇѿܰúÃÊÀ½ÆÄÇÐȸ Áø·á±Ç°í¾ÈÀ§¿øÀå
  • 2011 ~ ÇöÀçMember of the Society for Vascular Surgery (SVS)
  • 2003 ~ ÇöÀç´ëÇÑÇ÷°ü¿Ü°úÇÐȸ Æò»ýȸ¿ø
Ç÷°üÃÊÀ½ÆÄ(Ç÷°üÁúȯ¿¡¼­ÀÇ µàÇ÷º½º ½ºÄ³´×)
´ëÇ¥¼­Àû

Ç÷°üÃÊÀ½ÆÄ(Ç÷°üÁúȯ¿¡¼­ÀÇ µàÇ÷º½º ½ºÄ³´×)

  • ÀúÀÚ(±Û)R.EugeneZierler, Á¶ÁøÇö
  • ÃâÆÇ»ç°¡º»ÀÇÇÐ
  • ¹ßÇàÀÏ2013.02.12
Àú¼­ ¾ÆÀÌÄÜ

ÁýÇÊÀú¼­

ÃÑ 3°Ç
Á¦ ¸ñ ÇÏÁöÁ¤¸ÆÃÊÀ½ÆÄ
ÃâÆÇ»ç °¡º»ÀÇÇÐ ¹ßÇàÀÏ 2007.11.07
Á¦ ¸ñ Ç÷°üÃÊÀ½ÆÄ
ÃâÆÇ»ç °¡º»ÀÇÇÐ ¹ßÇàÀÏ 2007.05.20
¿¬±¸ ¾ÆÀÌÄÜ

ÁÖ¿ä³í¹®

ÃÑ 7°Ç
Á¦ ¸ñ A nationwide study of compliance of venoactive drugs in chronic venous disease patients
¹ßÇ¥³âµµ 2023 ¹ßÇ¥Áö ANNALS OF SURGICAL TREATMENT AND RESEARCH
Á¦ ¸ñ Public awareness of chronic venous disease in Korea
¹ßÇ¥³âµµ 2023 ¹ßÇ¥Áö Journal of Vascular Surgery: Venous and Lymphatic Disorders
Á¦ ¸ñ National trend of the treatment for chronic venous diseases in Korea between 2010 and 2020
¹ßÇ¥³âµµ 2023 ¹ßÇ¥Áö Annals of Surgical Treatment and Research
Á¦ ¸ñ Prevalence and Risk Factors of Abdominal Aortic Aneurysms Detected with Ultrasound in Korea and Belgium
¹ßÇ¥³âµµ 2023 ¹ßÇ¥Áö JOURNAL OF CLINICAL MEDICINE
Á¦ ¸ñ Prospective, Multicenter Study of Rotational Atherectomy with Antirestenotic Therapy for Infrainguinal Arterial Disease
¹ßÇ¥³âµµ 2023 ¹ßÇ¥Áö Annals of Vascular Surgery
Á¦ ¸ñ Complex Hypersensitivity and Irritation Reaction (CHAIR) Phenomenon after Cyanoacrylate Closure of Varicose Vein
¹ßÇ¥³âµµ 2023 ¹ßÇ¥Áö Vascular Specialist International
Á¦ ¸ñ Ultrasound Elastography to Differentiate the Thrombus and Plaque in Peripheral Arterial Diseases
¹ßÇ¥³âµµ 2022 ¹ßÇ¥Áö Vascular Specialist International

¸íÀÇqna ¸íÀÇ QnA

Q °¡Àå °ü½É ÀÖ´Â ºÐ¾ß¿Í ¾÷ÀûÀÌ ÀÖ´Ù¸é ¾Ë·ÁÁÖ¼¼¿ä

°¡Àå °ü½ÉÀÖ´Â ºÐ¾ß´Â º¹ºÎ´ëµ¿¸Æ·ù, ÇÏÁöµ¿¸ÆÁúȯ, ÇÏÁöÁ¤¸Æ·ùÀÔ´Ï´Ù. º¹ºÎ´ëµ¿¸Æ·ù¿¡ ´ëÇØ¼­´Â Áö¿ª»çȸ¸¦ Á÷Á¢ ¹æ¹®ÇÏ¿© Çѱ¹ÀÎ º¹ºÎ´ëµ¿¸Æ À¯º´·ü Á¶»ç¸¦ ¹ßÇ¥ÇÏ¿´½À´Ï´Ù. ÇÏÁöµ¿¸ÆÁúȯ¿¡ ´ëÇØ¼­´Â ÀÎÅͺ¥¼Ç°ú ¼ö¼úÀû Ä¡·á¸¦ Á¢¸ñÇÏ¿© °¡Àå È¿°úÀûÀÎ Ä¡·á¸¦ ½ÃÇàÇϰí ÀÖ°í, ÇÏÁöÁ¤¸Æ·ù¿¡ ´ëÇØ¼­´Â ¸¹Àº Áø·á°æÇèÀ» ¹ÙÅÁÀ¸·Î À¯¼öÀÇ ³í¹®À» ´Ù¼ö Ãâ°£ÇÏ¿´½À´Ï´Ù.

Q ȯÀÚ Áø·á¿¡ ÀÖ¾î °¡Àå Áß¿äÇÏ°Ô »ý°¢ÇÏ´Â °¡Ä¡´Â?

ÁúȯÀÇ °æÁß°ú À§±Þµµ¿¡ µû¶ó Ä¡·áÀÇ À§±Þ¼ºÀÌ ´Þ¶óÁöÁö¸¸, ȯÀÚ °³°³ÀÎÀ¸·Î º¸¸é ÁúȯÀÌ °æÁõÀ̵ç ÁßÁõÀÌµç ¸ðµÎ Áß¿äÇÕ´Ï´Ù. ȯÀÚ Áø·á¿¡ ÀÖ¾î °¡Àå Áß¿äÇÑ °¡Ä¡´Â ȯÀÚ¸¦ º¼ ¶§ ÁúȯÀ¸·Î º¸Áö ¾Ê°í, ȯÀÚ °³°³ÀÎÀÇ ¼ÒÁßÇÑ ÀΰÝü·Î º¸´Â °ÍÀÔ´Ï´Ù.

Q ȯÀڵ鿡°Ô ÀüÇÏ°í ½ÍÀº ¸»¾¸

Ç÷°üÁúȯÀº Æò¼Ò Ưº°ÇÑ Áõ»óÀÌ º¸ÀÌÁö ¾Ê´Ù°¡ °©ÀÛ½º·¹ Áõ»óÀÌ ÃâÇöÇϰí À§±ÞÇÑ »óȲ¿¡ À̸¨´Ï´Ù. °Ç°­ÇÑ Ç÷°ü À¯Áö¿Í Ç÷°üÁúȯÀÇ Á¤È®ÇÑ Ä¡·á¸¦ À§ÇØ ¿Â Á¤¼ºÀ» ´Ù ÇϰڽÀ´Ï´Ù.

¸íÀÇqna ¸íÀÇ ¼Ò¼Óº´¿ø

°­µ¿°æÈñ´ëÇб³º´¿ø

Á¾ÇÕº´¿ø
ÀüÈ­ ¾ÆÀÌÄÜ ´ëÇ¥¹øÈ£
1577-5800
À¥»çÀÌÆ® ¾ÆÀÌÄÜȨÆäÀÌÁö

ÁÖ¿ä½Ã¼³

ÀÀ±Þ½Ç ÀÀ±Þ½Ç
Ŭ¸®´Ð Ŭ¸®´Ð
Á¾ÇÕ°ËÁø¼¾ÅÍ Á¾ÇÕ°ËÁø¼¾ÅÍ
¾Ï¼¾ÅÍ ¾Ï¼¾ÅÍ
ÁÖÂ÷½Ã¼³ ÁÖÂ÷½Ã¼³

°­µ¿°æÈñ´ëÇб³º´¿øÀº Àǰú, ÇÑÀǰú, Ä¡°ú´ëÇÐÀ» ¸ðµÎ º¸À¯ÇÑ º´¿øÀ¸·Î, 3°³ ´ëÇк´¿øÀÇ ¼öÁØ ³ôÀº ÀÇ·á¼­ºñ½º¸¦ ÇÑ ¹ø¿¡ ¹ÞÀ» ¼ö ÀÖ´Ù. ¿¬¸éÀû 24,000¿© Æò º»°ü Áö»ó 14Ãþ, º°°ü Áö»ó 4ÃþÀÇ 800º´»óÀ» °®Ãè´Ù. ³úÁúȯ¡¤°üÀý¡¤Ã´Ãß µî Áúȯ Áß½ÉÀ¸·Î ƯȭµÈ ÇùÁø ÀÇ·á
¼­ºñ½º¸¦ Á¦°øÇÏ´Â ÀÇ¡¤ÇÑ ÇùÁø¼¾ÅÍ, ȯÀÚ ¼¼°è ÃÖ°í ¼öÁØÀÇ Áø·á½Ã½ºÅÛÀ» °®Ãá Àǰú
´ëÇк´¿ø, ÇÑÀÇÇÐÀ» ¼±µµÇÏ´Â ÇÑ¹æ ºê·£µåÆÄÀ§ 1À§ ÇÑÀǰú´ëÇк´¿ø¿Í Àü¹®¼º°ú ÆíÀǼºÀ» °®Ãá ȯÀÚ¸¸Á· º´¿øÀÎ Ä¡°ú´ëÇк´¿øÀÌ ÃÖ»óÀÇ ÀÇ·á¼­ºñ½º¸¦ Á¦°øÇϰí ÀÖ´Ù.

°­µ¿°æÈñ´ëÇб³º´¿ø À̹ÌÁö

¼­¿ïƯº°½Ã °­µ¿±¸ µ¿³²·Î 892

Ȩ
³»°¡ ¾Ë°íÀÖ´Â ¸íÀǸ¦ ÃßÃµÇØÁÖ¼¼¿ä